Pricing

Albany Molecular Research Inc (AMRI)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
CEO:
William S. Marth
Employees:
3085
21 CORPORATE CIRCLE, P O BOX 15098, ALBANY, NY, 12203-5154
5184640279

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Albany Molecular Research, Inc. engages in research and manufacturing organization providing customers drug discovery, development, and manufacturing services. It operates through three segments: Discovery and Development Services, Active Pharmaceutical Ingredients and Drug Product. The Discovery and Development Services segment provides comprehensive services from hit identification to investigational new drug, including drug lead discovery, library design and synthesis, synthetic and medicinal chemistry, in vitro biology and pharmacology, lead optimization, chemical development, drug metaboli® and pharmacokinetics and small-scale commercial manufacturing. The Active Pharmaceutical Ingredients segment includes pilot to commercial scale manufacturing of API, including intermediates and high potency and controlled substance manufacturing. The Drug Product segment includes formulation through commercial scale production of complex liquid-filled and lyophilized parenteral formulations. The company was founded by Thomas E. D'Ambra on June 20, 1991 and is headquartered in Albany, NY.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available